Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
Hayato Murakoshi, Chengcheng Zou, Nozomi Kuse, et al.
Retrovirology (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Efficient Induction of T Cells against Conserved HIV-1 Regions by Mosaic Vaccines Delivered as Self-Amplifying mRNA
Nathifa Moyo, Annette B. Vogel, Søren Buus, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 12, pp. 32-46
Open Access | Times Cited: 85
T cell-based strategies for HIV-1 vaccines
Bette Korber, Will Fischer
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 3, pp. 713-722
Open Access | Times Cited: 54
Why the HIV Reservoir Never Runs Dry: Clonal Expansion and the Characteristics of HIV-Infected Cells Challenge Strategies to Cure and Control HIV Infection
Chuen‐Yen Lau, Matthew A. Adan, Frank Maldarelli
Viruses (2021) Vol. 13, Iss. 12, pp. 2512-2512
Open Access | Times Cited: 33
Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials
Tomáš Hanke
Expert Review of Vaccines (2019) Vol. 18, Iss. 10, pp. 1029-1041
Open Access | Times Cited: 33
Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination
Mathieu Surénaud, Matthieu Montès, Cecilia S. Lindestam Arlehamn, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 9, pp. e1008011-e1008011
Open Access | Times Cited: 31
Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens
Chengcheng Zou, Hayato Murakoshi, Nozomi Kuse, et al.
Journal of Virology (2019) Vol. 93, Iss. 7
Open Access | Times Cited: 29
Early exposure to broadly neutralizing antibodies may trigger a dynamical switch from progressive disease to lasting control of SHIV infection
Rajat Desikan, Rubesh Raja, Narendra M. Dixit
PLoS Computational Biology (2020) Vol. 16, Iss. 8, pp. e1008064-e1008064
Open Access | Times Cited: 26
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W. Cohen, Andrew Fioré-Gartland, Stephen R. Walsh, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 8
Effective Activation of Human Antigen-Presenting Cells and Cytotoxic CD8+ T Cells by a Calcium Phosphate-Based Nanoparticle Vaccine Delivery System
Florian Scheffel, Torben Knuschke, Lucas Otto, et al.
Vaccines (2020) Vol. 8, Iss. 1, pp. 110-110
Open Access | Times Cited: 23
HLA-E–restricted HIV-1–specific CD8+ T cell responses in natural infection
Anju Bansal, Mika N. Gehre, Kai Qin, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 20
Conserved multiepitope vaccine constructs: A potent HIV-1 therapeutic vaccine in clinical trials
Elahe Akbari, Masoud Seyedinkhorasani, Azam Bolhassani
The Brazilian Journal of Infectious Diseases (2023) Vol. 27, Iss. 3, pp. 102774-102774
Open Access | Times Cited: 7
Comparison of HIV-1 Vif and Vpu accessory proteins for delivery of polyepitope constructs harboring Nef, Gp160 and P24 using various cell penetrating peptides
Kimia Kardani, Atieh Hashemi, Azam Bolhassani
PLoS ONE (2019) Vol. 14, Iss. 10, pp. e0223844-e0223844
Open Access | Times Cited: 21
In silico design and in vitro expression of novel multiepitope DNA constructs based on HIV-1 proteins and Hsp70 T-cell epitopes
Elahe Akbari, Kimia Kardani, Ali Namvar, et al.
Biotechnology Letters (2021)
Open Access | Times Cited: 16
Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach
Takayuki Chikata, Wayne Paes, Tomohiro Akahoshi, et al.
Journal of Virology (2019) Vol. 93, Iss. 17
Open Access | Times Cited: 18
Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and Breadth
Nathifa Moyo, Edmund G. Wee, Bette Korber, et al.
Vaccines (2020) Vol. 8, Iss. 3, pp. 360-360
Open Access | Times Cited: 17
Clinical and evolutionary consequences of HIV adaptation to HLA
Santiago Ávila‐Ríos, Jonathan M. Carlson, Mina John, et al.
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 3, pp. 194-204
Open Access | Times Cited: 16
Effect of epitope variant co-delivery on the depth of CD8 T cell responses induced by HIV-1 conserved mosaic vaccines
Edmund G. Wee, Nathifa Moyo, Zara Hannoun, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 21, pp. 741-753
Open Access | Times Cited: 14
Priming of HIV-1-specific CD8+ T cells with strong functional properties from naïve T cells
Nozomi Kuse, Xiaoming Sun, Tomohiro Akahoshi, et al.
EBioMedicine (2019) Vol. 42, pp. 109-119
Open Access | Times Cited: 15
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes
Tatiana M. García-Bates, Mariana L. Palma, Renee R. Anderko, et al.
EBioMedicine (2021) Vol. 63, pp. 103175-103175
Open Access | Times Cited: 11
Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa
Chama Chanda, Freddie Kibengo, Michael Mutua, et al.
(2024)
Closed Access | Times Cited: 1
Identification of a Clade-Specific HLA-C*03:02 CTL Epitope GY9 Derived from the HIV-1 p17 Matrix Protein
Samuel Kyobe, Savannah Mwesigwa, Gyaviira Nkurunungi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9683-9683
Open Access | Times Cited: 1
Novel Nested Peptide Epitopes Recognized by CD4+ T Cells Induced by HIV-1 Conserved-Region Vaccines
Nicola Borthwick, Sandra Silva-Arrieta, Anuska Llano, et al.
Vaccines (2020) Vol. 8, Iss. 1, pp. 28-28
Open Access | Times Cited: 11
Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control
Hayato Murakoshi, Madoka Koyanagi, Tomohiro Akahoshi, et al.
EBioMedicine (2018) Vol. 36, pp. 103-112
Open Access | Times Cited: 10
Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya
Yehia S. Mohamed, Nicola Borthwick, Nathifa Moyo, et al.
Vaccines (2020) Vol. 8, Iss. 2, pp. 260-260
Open Access | Times Cited: 9
Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques
Dariusz K. Murakowski, John P. Barton, Lauren Peter, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 5
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top